Freenome's Enhanced Colorectal Cancer Blood Test Achieves Significant Sensitivity Improvements Freenome reveals impressive advancements in its colorectal cancer blood test, showcasing an 85% sensitivity for CRC and improved detection rates for precancerous lesions, signaling a new era in early cancer diagnostics.

Freenome's Enhanced Colorectal Cancer Blood Test Achieves Significant Sensitivity Improvements #USA #Brisbane #cancer_detection #Freenome #CRC_Test